A new blood screening test could help to identify ovarian cancer in its early stages when few symptoms are present, School of Medicine researchers reported in the May 10 issue of Proceedings of the National Academies of Sciences (PNAS).
Epithelial ovarian cancer is the leading cause of gynecologic cancer deaths in the United States and is three times more lethal than breast cancer. It is usually not diagnosed until its advanced stages and has come to be known as the "silent killer."
"Early diagnosis can help prolong or save lives, but clinicians currently have no sensitive screening method because the disease shows few symptoms," says the study's lead author Dr. Gil Mor, associate professor in the Department of Obstetrics, Gynecology & Reproductive Sciences.
Mor conducted the research with David Ward, deputy director of the Nevada Cancer Institute. They developed and tested a new blood test for ovarian cancer based on four proteins: leptin, prolactin, osteopontin and insulin-like growth factor-II. If the level of two or more of these biomarkers for a patient falls within a certain warning area, the test will predict that she has cancer. In a test group of over 200 ovarian cancer patients and healthy women, the test showed 95% sensitivity (fraction correctly diagnosed with cancer) and 95% specificity (fraction correctly diagnosed as cancer-free).
Each of the proteins had been previously suggested as a good cancer biomarker, though not as a set. In this study, no single protein could completely distinguish the cancer patients from the healthy controls.
Other authors on the study are Irene Visintin, Yinglei Lai, Hongyu Zhao, Dr. Peter Schwartz, Dr. Thomas Rutherford, Luo Yue and Patricia Bray-Ward.
-- By Karen Peart
T H I S
W E E K ' SS T O R I E S
Renowned Harvard scholar named dean of Yale SOM
F&ES group gets lessons in global, local activism during Kenya trip
Champion archer aims to achieve state of grace when wielding her bow
Report details University's progress on environmental issues
'Mugsy' proves to be top dog in Handsome Dan competition
Whistler works, recent acquisitions showcased in exhibitions
Scholar of womanist theology and expert on the art of preaching . . .
Researchers illuminate how bacteria becomes resistant to antibiotics
YALE LIBRARY NEWS'From Intent to Serendipity' features unique items from Yale's archives
Yale will lead effort to create Middle East Electronic Library
Muslims' contributions to field of medicine documented in display
Exhibit recalls life (and death) of American patriot Nathan Hale
Grants from Seaver Institute support medical and library projects
African-American women report wider range of menopausal symptoms
International array of scholars to discuss 'Culture in the World'
Events to examine the risks and benefits of biopharming
MEDICAL SCHOOL NEWSTalk by Yale scientist to highlight annual Student Research Day
Study shows the use of the herb black cohosh can affect . . .
Scientists pinpoint protein molecule that the body uses . . .
Researchers find genetic risk-factors for alcoholism . . .
Program to assess ways to improve care of children
Conference to focus on origins of Borderline Personality Disorder
Honorees applaud new research on women's health
Barry on committee calling for creation of U.S. health corps
Yale neurologists cited by Lancet . . .
Awards to two faculty members support improved race relations
Engineer wins grant for research in nanotechnology
Painting at the Y
IN MEMORIAMDr. Elisha Atkins, an authority on the function of fever . . .
James Fesler, public administration scholar . . .
Memorial service for Jacques Guicharnaud
Yale Books in Brief
Campus Notes
From sneakers to playgrounds